OYST - Oyster Point Pharma Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript
Oyster Point Pharma, Inc. (OYST) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Arty Ahmed - Vice President, Investor Relations Dr. Jeffrey Nau - President and CEO Dan Lochner - Chief Financial Officer John Snisarenko - Chief Commercial Officer Conference Call Participants Ken Cacciatore - Cowen and Company Chris Neyor - JPMorgan Cory Jubinville - LifeSci Capital Presentation Operator Good evening. And welcome to Oyster Point Pharma’s First Quarter 2022 Earnings Conference Call. My name is Shannon, and I will be your operator today. After the company’s formal remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to Mr. Arty Ahmed, Oyster Point Pharma’s VP, Investor Relations. Please go ahead. Arty Ahmed Thank you, and good evening, everyone. And welcome to Oyster Point Pharma’s first quarter 2022 earnings conference call. This evening, we issued a press
For further details see:
Oyster Point Pharma, Inc.'s (OYST) CEO Dr. Jeffrey Nau on Q1 2022 Results - Earnings Call Transcript